The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Neville Robert N since year 2005.
The trader's CIK number is 1703487.
At the time of this reporting, Neville Robert N is the Chief Executive Officer of Adventrx Pharmaceuticals Inc .
(stock ticker symbol ANX).
See this page for all insider trading activities at Adventrx Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-06-07||SVRA||Adventrx Pharmaceuticals Inc||Buy||52,250||4.75||248,187|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Neville Robert N (Chief Executive Officer of Adventrx Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.